Skip to main content

Acute Quadriplegic Myopathy: An Acquired “Myosinopathy”

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 642))

Abstract

Acquired neuromuscular disorders have been shown to be very common in critically ill patients receiving prolonged mechanical ventilation in the intensive care unit (ICU). Acute Quadriplegic Myopathy (AQM) is a specific acquired myopathy in ICU patients. Patients with AQM are characterized by severe muscle weakness and atrophy of spinal nerve innervated limb and trunk muscles, while cranial nerve innervated craniofacial muscles, sensory and cognitive functions are spared or less affected. The muscle weakness is associated with altered muscle membrane properties and a preferential loss of the motor protein myosin and myosin-associated thick filament proteins. Prolonged mechanical ventilation, muscle unloading, postsynaptic block of neuromuscular transmission, sepsis and systemic corticosteroid hormone treatment have been suggested as important triggering factors in AQM. However, the exact mechanisms underlying the loss of thick filament proteins are not known, though enhanced myofibrillar protein degradation in combination with a downregulation of protein synthesis at the transcriptional level play important roles.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet 1977; 2(8038):615.

    Article  PubMed  CAS  Google Scholar 

  2. Lacomis D, Zochodne DW, Bird SJ. Critical illness myopathy. Muscle Nerve 2000; 23(12):1785–1788.

    Article  PubMed  CAS  Google Scholar 

  3. Rich MM, Teener JW, Raps EC et al. Muscle inexcitability in patients with reversible paralysis following steroids and neuromuscular blockade. Muscle Nerve 1998; 21(9):1231–1232.

    Article  PubMed  CAS  Google Scholar 

  4. Rich MM, Raps EC, Bird SJ. Distinction between acute myopathy syndrome and critical illness polyneuropathy. Mayo Clin Proc 1995; 70(2):198–200.

    PubMed  CAS  Google Scholar 

  5. Rich MM, Pinter MJ, Kraner SD et al. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 1998; 43(2):171–179.

    Article  PubMed  CAS  Google Scholar 

  6. Rich MM, Teener JW, Raps EC et al. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996; 46(3):731–736.

    PubMed  CAS  Google Scholar 

  7. Rich MM, Bird SJ, Raps EC et al. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997; 20(6):665–673.

    Article  PubMed  CAS  Google Scholar 

  8. De Jonghe B, Sharshar T, Lefaucheur JP et al. Paresis acquired in the intensive care unit: A prospective multicenter study. JAMA 2002; 288(22):2859–2867.

    Article  PubMed  Google Scholar 

  9. Leijten FS, Harinck-de Weerd JE, Poortvliet DC et al. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995; 274(15):1221–1225.

    Article  PubMed  CAS  Google Scholar 

  10. Friedrich O, Fink RH, Hund E. Understanding critical illness myopathy: approaching the pathomechanism. J Nutr 2005; 135(7):1813S–1817S.

    PubMed  CAS  Google Scholar 

  11. Rudis MI, Guslits BJ, Peterson EL et al. Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit. Crit Care Med 1996; 24(10):1749–1756.

    Article  PubMed  CAS  Google Scholar 

  12. Seneff MG, Wagner D, Thompson D et al. The impact of long-term acute-care facilities on the out-come and cost of care for patients undergoing prolonged mechanical ventilation. Crit Care Med 2000; 28(2):342–350.

    Article  PubMed  CAS  Google Scholar 

  13. Cheung AM, Tansey CM, Tomlinson G et al. 2-Year outcomes, health care use and costs in survivors of ARDS. Am J Respir Crit Care Med 2006; 174(5):528–544.

    Article  Google Scholar 

  14. Herridge MS, Cheung AM, Tansey CM et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348(8):683–693.

    Article  PubMed  Google Scholar 

  15. Visser LH. Critical illness polyneuropathy and myopathy: Clinical features, risk factors and prognosis. Eur J Neurol 2006; 13(11):1203–1212.

    Article  PubMed  CAS  Google Scholar 

  16. al-Lozi MT, Pestronk A, Yee WC et al. Rapidly evolving myopathy with myosin-deficient muscle fibers. Ann Neurol 1994; 35(3):273–279.

    Article  PubMed  CAS  Google Scholar 

  17. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuro nium during steroid treatment. Muscle Nerve 1991; 14(11):1131–1139.

    Article  PubMed  CAS  Google Scholar 

  18. Larsson L, Li X, Edstrom L et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels [see comments]. Crit Care Med 2000; 28(1):34–45.

    Article  PubMed  CAS  Google Scholar 

  19. Matsumoto N, Nakamura T, Yasui Y et al. Analysis of muscle proteins in acute quadriplegic myopathy. Muscle Nerve 2000; 23(8):1270–1276.

    Article  PubMed  CAS  Google Scholar 

  20. Ochala J, Larsson L. Effects of myosin heavy chain loss on the regulation of Ca2+-activation in single human skeletal muscle fibres. Submitted for publication 2007.

    Google Scholar 

  21. Banduseela V, Ochala J, Lamberg K et al. Muscle paralysis and myosin loss in a patient with cancer cachexia. Acta Myologica. In press, 2007.

    Google Scholar 

  22. Hund E. Neurological complications of sepsis: Critical illness polyneuropathy and myopathy. J Neurol 2001; 248(11):929–934.

    Article  PubMed  CAS  Google Scholar 

  23. Druschky A, Herkert M, Radespiel-Troger M et al. Critical illness polyneuropathy: Clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 2001; 27(4):686–693.

    Article  PubMed  CAS  Google Scholar 

  24. Di Giovanni S, Knoblach SM, Brandoli C et al. Gene profiling in spinal cord injury shows role of cell cycle in neuronal death. Ann Neurol 2003; 53(4):454–468.

    Article  PubMed  Google Scholar 

  25. Showalter CJ, Engel AG. Acute quadriplegic myopathy: Analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997; 20(3):316–322.

    Article  PubMed  CAS  Google Scholar 

  26. Helliwell TR, Wilkinson A, Griffiths RD et al. Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol 1998; 24(6):507–517.

    Article  PubMed  CAS  Google Scholar 

  27. Di Giovanni S, Molon A, Broccolini A et al. Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 2004; 55(2):195–206.

    Article  PubMed  Google Scholar 

  28. Norman H, Hedström Y, Andersson P et al. Changes in myofibrillar protein and mRNA expression in patients with acute quadriplegic myopathy during recovery. In review, 2007.

    Google Scholar 

  29. Thomason DB, Biggs RB, Booth FW. Protein metabolism and beta-myosin heavy-chain mRNA in unweighted soleus muscle. Am J Physiol 1989; 257(2 Pt 2):R300–305.

    PubMed  CAS  Google Scholar 

  30. Thomason DB, Booth FW. Atrophy of the soleus muscle by hindlimb unweighting. J Appl Physiol 1990; 68(1):1–12.

    Article  PubMed  CAS  Google Scholar 

  31. Shanely RA, Van Gammeren D, Deruisseau KC et al. Mechanical ventilation depresses protein synthesis in the rat diaphragm. Am J Respir Crit Care Med 2004; 170(9):994–999.

    Article  PubMed  Google Scholar 

  32. Giger JM, Haddad F, Qin AX et al. Effect of unloading on type I myosin heavy chain gene regulation in rat soleus muscle. J Appl Physiol 2005; 98(4):1185–1194.

    Article  PubMed  CAS  Google Scholar 

  33. Huey KA, Roy RR, Haddad F et al. Transcriptional regulation of the type I myosin heavy chain promoter in inactive rat soleus. Am J Physiol Cell Physiol 2002; 282(3):C528–537.

    PubMed  CAS  Google Scholar 

  34. Nates JL, Cooper DJ, Day B et al. Acute weakness syndromes in critically ill patients—A reappraisal. Anaesth Intensive Care 1997; 25(5):502–513.

    PubMed  CAS  Google Scholar 

  35. Larsson L, Roland A. Drug induced tetraparesis and loss of myosin. Mild types are probably overlooked. Lakartidningen 1996; 93(23):2249–2254.

    PubMed  CAS  Google Scholar 

  36. Larsson L. Experimental animal models of muscle wasting in intensive care unit patients. Crit Care Med 2007; 35(9 Suppl):484–487.

    Article  Google Scholar 

  37. Rich MM, Pinter MJ. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 2003; 547(Pt 2):555–566.

    Article  PubMed  CAS  Google Scholar 

  38. Rich MM, Pinter MJ. Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 2001; 50(1):26–33.

    Article  PubMed  CAS  Google Scholar 

  39. Norman H, Nordquist J, Andersson P et al. Impact of postsynaptic block of neuromuscular transmission, muscle unloading and mechanical ventilation on skeletal muscle protein and mRNA expression. Pflugers Arch 2006; I10:1007/s00424-006-0110-5.

    Google Scholar 

  40. Nordquist J, Höglund AS, Norman H et al. Transcription factors in muscle atrophy caused by postsynaptic block of neuromuscular transmission and muscle unloading in rats. Mol Med 2007; 13(9–10):461–70.

    PubMed  CAS  Google Scholar 

  41. Norman H, Kandala K, Kolluri R et al. A porcine model of acute quadriplegic myopathy: A feasability study. Acta Anaesthesiol Scand 2006; 50(9):1058–67.

    Article  PubMed  CAS  Google Scholar 

  42. Ochala J, Bandusela V, Norman H et al. Triggering factors and mechanisms underlying muscle weakness in AQM, experimental studies in a porcine AQM model. In preparation 2007.

    Google Scholar 

  43. Dworkin BR, Dworkin S. Learning of physiological responses: I. Habituation, sensitization and classical conditioning. Behav Neurosci 1990; 104(2):298–319.

    Article  PubMed  CAS  Google Scholar 

  44. Dworkin BR, Dworkin S. Baroreflexes of the rat. III. Open-loop gain and electroencephalographic arousal. Am J Physiol Regul Integr Comp Physiol 2004; 286(3):R597–605.

    PubMed  CAS  Google Scholar 

  45. Dworkin BR, Dworkin S, Tang X. Carotid and aortic baro reflexes of the rat: I. Open-loop steady-state properties and blood pressure variability. Am J Physiol Regul Integr Comp Physiol 2000; 279(5): R1910–1921.

    PubMed  CAS  Google Scholar 

  46. Dworkin BR, Tang X, Snyder AJ et al. Carotid and aortic baroreflexes of the rat: II. Open-loop frequency response and the blood pressure spectrum. Am J Physiol Regul Integr Comp Physiol 2000; 279(5): R1922–1933.

    PubMed  CAS  Google Scholar 

  47. Nordqvist J, Höglund AS, Norman H et al. Transcription factors in muscle atrophycaused by postsynaptic block of neuromuscular transmission and muscle unloading in rats. Molecular Medicine 2007; In review.

    Google Scholar 

  48. Norman H, Nordquist J, Andersson P et al. Impact of postsynaptic block of neuromuscular transmission, muscle unloading and mechanical ventilation on skeletal muscle protein and mRNA expression. Pflugers Arch 2006; 453(1):53–66.

    Article  PubMed  CAS  Google Scholar 

  49. Griffiths RD, Jones C, Palmer TE. Outcome of nutrition therapies in the intensive care unit. Nutrition 1995; 11(2 Suppl):224–228.

    PubMed  CAS  Google Scholar 

  50. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997; 13(4):295–302.

    PubMed  CAS  Google Scholar 

  51. Griffiths RD, Palmer TE, Jones C. Parenteral glutamine supply in intensive care patients. Nutrition 1996; 12(11–12 Suppl):s73–75.

    Article  Google Scholar 

  52. Jones C, Palmer TE, Griffiths RD. Randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition 1999; 15(2):108–115.

    Article  PubMed  CAS  Google Scholar 

  53. Griffiths RD, Palmer TE, Helliwell T et al. Effect of passive stretching on the wasting of muscle in the critically ill. Nutrition 1995; 11(5):428–432.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Landes Bioscience and Springer Science+Business Media

About this chapter

Cite this chapter

Larsson, L. (2008). Acute Quadriplegic Myopathy: An Acquired “Myosinopathy”. In: Laing, N.G. (eds) The Sarcomere and Skeletal Muscle Disease. Advances in Experimental Medicine and Biology, vol 642. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84847-1_8

Download citation

Publish with us

Policies and ethics